- Home
- SLNO vs FUL Comparison
SLNO vs FUL Comparison
Compare SLNO & FUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- FUL
- Stock Information
- Founded
- SLNO 1999
- FUL 1887
- Country
- SLNO United States
- FUL United States
- Employees
- SLNO N/A
- FUL N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- FUL Home Furnishings
- Sector
- SLNO Health Care
- FUL Industrials
- Exchange
- SLNO Nasdaq
- FUL Nasdaq
- Market Cap
- SLNO 3.8B
- FUL 3.2B
- IPO Year
- SLNO 2014
- FUL N/A
- Fundamental
- Price
- SLNO $86.00
- FUL $55.58
- Analyst Decision
- SLNO Strong Buy
- FUL Hold
- Analyst Count
- SLNO 9
- FUL 5
- Target Price
- SLNO $105.11
- FUL $67.25
- AVG Volume (30 Days)
- SLNO 1.5M
- FUL 445.8K
- Earning Date
- SLNO 08-06-2025
- FUL 09-24-2025
- Dividend Yield
- SLNO N/A
- FUL 1.69%
- EPS Growth
- SLNO N/A
- FUL N/A
- EPS
- SLNO N/A
- FUL 1.84
- Revenue
- SLNO N/A
- FUL $3,527,969,000.00
- Revenue This Year
- SLNO N/A
- FUL N/A
- Revenue Next Year
- SLNO $506.77
- FUL $3.24
- P/E Ratio
- SLNO N/A
- FUL $30.24
- Revenue Growth
- SLNO N/A
- FUL N/A
- 52 Week Low
- SLNO $41.50
- FUL $47.56
- 52 Week High
- SLNO $90.32
- FUL $86.71
- Technical
- Relative Strength Index (RSI)
- SLNO 54.38
- FUL 35.66
- Support Level
- SLNO $83.53
- FUL $59.57
- Resistance Level
- SLNO $89.12
- FUL $61.59
- Average True Range (ATR)
- SLNO 2.65
- FUL 1.32
- MACD
- SLNO -0.34
- FUL -0.76
- Stochastic Oscillator
- SLNO 56.91
- FUL 12.46
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About FUL H. B. Fuller Company
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. It generates the maximum revenue from hygiene, health and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based and solvent-based products for applications in various markets, including packaging , converting, nonwoven and hygiene (disposable diapers, feminine care and medical garments) and health and beauty. The company generates around half of its revenue in the United States.